LeMaitre Vascular, Inc. (LMAT) Financial Statements
LeMaitre Vascular, Inc. (LMAT) reported trailing twelve-month revenue of $262.4M (up 11.8% year on year) and net income of $65.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $73.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LMATLeMaitre Vascular, Inc.Follow LMAT — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- 29.6
- Dividend yield
- 1.1%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57.7 | 56.7 | 64.5 | 71.1 | 78.4 | 89.2 | 100.9 | 105.6 | 117.2 | 129.4 | 154.4 | 161.7 | 193.5 | 219.9 | 249.6 | 262.4 | |
| Gross profit | 40.2 | 40.9 | 45.1 | 48.4 | 54.2 | 62.9 | 70.7 | 73.9 | 79.9 | 84.6 | 101.4 | 104.9 | 127.0 | 150.9 | 178.5 | 191.3 | |
| Research & development | 4.4 | 5.1 | 5.2 | 4.7 | 5.5 | 6.1 | 6.6 | 8.2 | 9.3 | 10.1 | 11.8 | 13.3 | 17.0 | 15.7 | 14.1 | 15.4 | |
| Operating income | 3.7 | 4.2 | 4.5 | 6.3 | 11.5 | 16.3 | 21.1 | 28.2 | 21.2 | 28.8 | 36.4 | 26.8 | 36.7 | 52.3 | 67.9 | 77.3 | |
| Pre-tax income | 3.8 | 4.0 | 4.3 | 6.3 | 11.4 | 16.2 | 21.1 | 28.4 | 21.7 | 27.4 | 34.3 | 27.5 | 39.5 | 56.9 | 75.2 | 84.7 | |
| Income tax | 1.6 | 1.4 | 1.1 | 2.4 | 3.7 | 5.7 | 3.9 | 5.5 | 3.7 | 6.1 | 7.4 | 6.9 | 9.4 | 12.8 | 17.5 | 19.1 | |
| Net income | 2.1 | 2.6 | 3.2 | 3.9 | 7.8 | 10.6 | 17.2 | 22.9 | 17.9 | 21.2 | 26.9 | 20.6 | 30.1 | 44.0 | 57.7 | 65.7 | |
| Diluted EPS ($) | 0.13 | 0.16 | 0.20 | 0.23 | 0.42 | 0.55 | 0.86 | 1.13 | 0.88 | 1.04 | 1.25 | 0.93 | 1.34 | 1.93 | 2.52 | 2.85 | |
| Diluted shares (mn) | 16.0 | 15.6 | 15.8 | 17.0 | 18.3 | 19.2 | 20.0 | 20.2 | 20.3 | 20.5 | 21.5 | 22.2 | 22.4 | 22.8 | 22.9 | — |
USD millions · SEC XBRL
LeMaitre Vascular, Inc. — questions
- What is LeMaitre Vascular, Inc.'s revenue?
- $262.4M over the twelve months to 2026-06-30, up 11.8% year on year, from its 10-Q and 10-K filings.
- What is LeMaitre Vascular, Inc.'s net income?
- $65.7M over the twelve months to 2026-06-30.
- What is LeMaitre Vascular, Inc.'s free cash flow?
- $73.8M over the twelve months to 2026-06-30.
- What are LeMaitre Vascular, Inc.'s diluted earnings per share?
- $2.85 over the twelve months to 2026-06-30.
Every figure on this page comes from LeMaitre Vascular, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.